US · THC · MEDICAL - CARE FACILITIES
Tenet Healthcare Corporation (THC) intrinsic value and stock valuation
$263.19as of 2026-11-21 · Mkt cap 21.11B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Tenet Healthcare Corporation DCF and intrinsic value
InvestorsCraft values THC with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from THC’s statements →
Tenet Healthcare Corporation Graham Number
Graham Number: $186.96d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- HCA Healthcare, Inc. (HCA) $475.57
- DaVita Inc. (DVA) $161.03
- Encompass Health Corporation (EHC) $133.65
- The Ensign Group, Inc. (ENSG) $176.32
- Universal Health Services, Inc. (UHS) $179.43
- Brookdale Senior Living Inc. (BKD) $8.86
- Acadia Healthcare Company, Inc. (ACHC) $34.60
- Addus HomeCare Corporation (ADUS) $122.50
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $21.3B | $20.7B | $20.5B | $19.2B | $19.5B |
| Operating income | $3.44B | $5.96B | $2.51B | $2.33B | $2.87B |
| Net income | $1.41B | $3.2B | $611M | $411M | $914M |
| EPSd | $15.5M | $32.7M | $5.83M | $3.72M | $8.42M |
| Operating cash flow | $3.54B | $2.05B | $2.37B | $1.08B | $1.57B |
| Capital expenditure | -$-1.01B | -$-931M | -$-751M | -$-762M | -$-658M |
| Free cash flow | $2.53B | $1.12B | $1.62B | $321M | $910M |
| Total assets | $29.7B | $28.9B | $28.3B | $27.2B | $27.6B |
| Total debt | $13.2B | $14.3B | $15B | $15.1B | $15.6B |
| Net debt | $10.3B | $11.3B | $13.8B | $14.2B | $13.3B |
| Total equity | $8.97B | $8.55B | $5.51B | $4.61B | $4.26B |
| Cash and short-term investments | $2.88B | $3.02B | $1.23B | $858M | $2.36B |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $21.3B | $20.7B | $20.5B | $19.2B | $19.5B |
| Cost of revenue | $3.78B | $12.5B | $12.7B | $12.1B | $12.2B |
| Gross profit | $17.5B | $8.21B | $7.81B | $7.05B | $7.27B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $8.71B | $8.8B | $418M | $412M | $412M |
| Other expenses | $5.39B | -$-6.55B | $4.88B | $4.3B | $3.99B |
| Operating expenses | $14.1B | $2.25B | $5.3B | $4.72B | $4.4B |
| Cost and expenses | $17.9B | $14.7B | $18B | $16.8B | $16.6B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $821M | $826M | $901M | $890M | $923M |
| Depreciation and amortization | $863M | $818M | $870M | $841M | $855M |
| Ebitda | $4.48B | $6.89B | $3.39B | $3.08B | $3.67B |
| Operating income | $3.44B | $5.96B | $2.51B | $2.33B | $2.87B |
| Total other income/expenses, net | -$-639M | -$-708M | -$-893M | -$-988M | -$-983M |
| Income before tax | $2.8B | $5.25B | $1.62B | $1.35B | $1.89B |
| Income tax expense | $433M | $1.18B | $306M | $344M | $411M |
| Net income | $1.41B | $3.2B | $611M | $411M | $914M |
| Weighted average shares outstanding | $90.2M | $96.9M | $101.6M | $106.9M | $106.8M |
| Weighted average diluted shares outstanding | $90.8M | $97.9M | $104.8M | $110.5M | $108.6M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.88B | $3.02B | $1.23B | $858M | $2.36B |
| Net receivables | $2.57B | $3.05B | $3.4B | $3.46B | $3.31B |
| Inventory | $348M | $346M | $411M | $405M | $384M |
| Total current assets | $7.85B | $7.68B | $7.17B | $5.98B | $7.08B |
| Property, plant and equipment, net | $7.45B | $7.09B | $7.32B | $7.59B | $7.43B |
| Goodwill and intangible assets | $12.5B | $12.1B | $11.7B | $11.5B | $10.8B |
| Long-term investments | $1.44B | $1.81B | $1.89B | $1.83B | $2.03B |
| Total non-current assets | $21.8B | $21.3B | $21.1B | $21.2B | $20.5B |
| Total assets | $29.7B | $28.9B | $28.3B | $27.2B | $27.6B |
| Accounts payable | $1.36B | $1.29B | $1.41B | $1.5B | $1.3B |
| Short-term debt | $79M | $296M | $120M | $145M | $135M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $110M | $959M |
| Total current liabilities | $4.46B | $4.31B | $4.76B | $4.48B | $5.11B |
| Long-term debt | $13.1B | $14B | $14.9B | $14.9B | $15.5B |
| Deferred revenue, non-current | $0.00 | $13M | $0.00 | $13M | $15M |
| Total non-current liabilities | $16.2B | $16.1B | $18B | $18.1B | $18.2B |
| Capital lease obligations | $0.00 | $1.34B | $0.00 | $0.00 | $0.00 |
| Total liabilities | $20.7B | $20.4B | $22.8B | $22.5B | $23.3B |
| Common stock | $8M | $8M | $8M | $8M | $8M |
| Retained earnings | $4.42B | $3.01B | -$-192M | -$-803M | -$-1.21B |
| Accumulated other comprehensive income (loss) | -$-181M | -$-180M | -$-181M | -$-181M | -$-233M |
| Total equity | $8.97B | $8.55B | $5.51B | $4.61B | $4.26B |
| Total investments | $1.44B | $1.81B | $1.89B | $1.83B | $2.03B |
| Total debt | $13.2B | $14.3B | $15B | $15.1B | $15.6B |
| Net debt | $10.3B | $11.3B | $13.8B | $14.2B | $13.3B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $1.41B | $4.06B | $1.31B | $1B | $1.48B |
| Depreciation and amortization | $886M | $818M | $870M | $841M | $855M |
| Stock-based compensation | $104M | $67M | $66M | $56M | $56M |
| Change in working capital | -$-44M | $136M | $71M | -$-1.14B | -$-737M |
| Accounts receivable | $20M | $245M | -$-29M | -$-140M | -$-197M |
| Inventory | -$-73M | -$-86M | -$-139M | -$-64M | -$-52M |
| Accounts payable | $0.00 | -$-30M | $215M | -$-898M | -$-584M |
| Net cash provided by operating activities | $3.54B | $2.05B | $2.37B | $1.08B | $1.57B |
| Investments in property, plant and equipment | -$-1.01B | -$-931M | -$-751M | -$-762M | -$-658M |
| Acquisitions, net | -$-308M | -$-571M | -$-224M | -$-234M | -$-1.22B |
| Net cash used for investing activities | -$-1.28B | $3.43B | -$-969M | -$-808M | -$-714M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-1.44B | -$-672M | -$-200M | -$-250M | $0.00 |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | -$-2.4B | -$-3.69B | -$-1.04B | -$-1.78B | -$-936M |
| Net change in cash | -$-136M | $1.79B | $370M | -$-1.51B | -$-82M |
| Cash at end of period | $2.88B | $3.02B | $1.23B | $858M | $2.36B |
| Operating cash flow | $3.54B | $2.05B | $2.37B | $1.08B | $1.57B |
| Capital expenditure | -$-1.01B | -$-931M | -$-751M | -$-762M | -$-658M |
| Free cash flow | $2.53B | $1.12B | $1.62B | $321M | $910M |
Line items
Line items
Line items
About Tenet Healthcare Corporation
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.
- CEO
- Saumya Sutaria
- Employees
- 99K
- Beta
- 1.27
Included in
Explore
Frequently asked questions
What is the intrinsic value of Tenet Healthcare Corporation (THC)?
Tenet Healthcare Corporation (THC) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is THC undervalued?
THC trades at a price of $263.19 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.